Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Life sciences M&A value of portfolio optimization worldwide by therapeutic area 2020

Oncology was the therapeutic area with the largest potential in M&A value of protfolio optimization, as of early 2020. The potential deal multiplier stood at six, with a potential asset value of 84 billion U.S. dollars. This statistic illustrates the life sciences M&A value of portfolio optimization worldwide as of 2020, by five selected therapeutic areas.

Life sciences M&A value of portfolio optimization worldwide as of 2020, by select therapeutic area

You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

January 2020

Region

Worldwide

Survey time period

as of January 2020

Number of respondents

base: 30 leading life sciences companies

Supplementary notes

Modeling assumes assets are divestiture candidates if owners’ revenues total 3% or less of total therapy area revenues.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Biotechnology in Germany"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.